StreetInsider.com News Articles

DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)

Fri, 31 Jul 2026 08:30:00 -0400

Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store

TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI" or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx^™ and blockchain-enabled smart contracts platform PharmacyChain^™ to provide integrated solutions for the compliant monetization of health data by market participants, today announced that its wholly-owned online pharmacy, Corexa Pharmacy (www.CorexaRx.com/store), has begun direct-to-consumer (DTC) distribution of Tollovid^®, a 3CL protease inhibitor dietary supplement, and Galactovid^™, a medical food

DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)

Fri, 31 Jul 2026 08:30:00 -0400

Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store

DataMeds AI and Datavault AI expand healthcare data licensing deal

Wed, 29 Jul 2026 10:17:09 -0400

DataMeds AI, Inc. (NASDAQ: MEDS) and Datavault AI Inc. (NASDAQ: DVLT) announced an amendment to their existing definitive agreement, expanding a blockchain technology licensing relationship to cover all commercial healthcare, healthspan, and wellness applications of Datavault AI's intellectual property.

The original agreement was limited to pharmaceutical distribution. Under the expanded terms, Datavault AI's data monetization and real-world asset tokenization technologies will be integrated into DataMeds AI's EinsteinRx platform, covering pharmacy, medical, laboratory, and wearables data environments.

The companies said the amended agreement was executed ahead of the completion of remaining closing conditions to allow for the launch of the Health Lives Here

DataMeds AI and Datavault AI expand healthcare data licensing deal

Wed, 29 Jul 2026 10:17:09 -0400

The companies said the amended agreement was executed ahead of the completion of remaining closing conditions to allow for the launch of the Health Lives Here

DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License

Wed, 29 Jul 2026 10:15:00 -0400

Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform

Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data

TAMPA, FL / ACCESS Newswire / July 29, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx^™ and blockchain-enabled smart contacts platform PharmacyChain^™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization of health data and Datavault AI Inc. ("Datavault AI"

DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License

Wed, 29 Jul 2026 10:15:00 -0400

Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform

Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data

DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License

Wed, 29 Jul 2026 10:15:00 -0400

Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform

Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data

DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License

Wed, 29 Jul 2026 10:15:00 -0400

Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform

Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data

Datavault AI amends DataMeds deal to expand healthcare data license

Wed, 29 Jul 2026 09:06:43 -0400

Datavault AI Inc. (NASDAQ: DVLT) has amended its definitive agreement with DataMeds AI, Inc. (NASDAQ: MEDS) to expand a blockchain technology licensing relationship beyond pharmaceutical distribution to cover all commercial healthcare, healthspan, and wellness applications of Datavault AI's intellectual property, according to a press release.

Under the amended terms, Datavault AI will receive common shares representing approximately 19.9% of DataMeds common stock upon closing, replacing previously planned preferred shares. The change was made to optimize the transaction for tax purposes. The share issuance remains subject to closing conditions, including DataMeds' acquisition of two QOLPOM intellectual property portfolios from EOS Technology Holdings

Datavault AI amends DataMeds deal to expand healthcare data license

Wed, 29 Jul 2026 09:06:43 -0400

Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI

Wed, 29 Jul 2026 09:05:00 -0400